Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
— Almost half of patients in active surveillance avoided cystectomy during 40 months of follow-up
Latest in Oncology/Hematology
One warns of "dangerous game" in continuing Medicare pay cuts
Study paves the way for quadruple therapy in patients not eligible for a stem cell transplant
Reduced toxicity and improved convenience position new treatments for broader use
Rapid evaluation and novel therapies may improve outcomes for these patients
Reduced toxicity and improved convenience position new treatments for broader use
Rapid evaluation and novel therapies may improve outcomes for these patients
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed
Meta-analysis shows inverse dose-response relationship for both beverages
Also in TTHealthWatch: electronic nudges for flu shots
News, features, and commentary about cancer-related issues
Lack of biomarkers handicaps decision making in era of expanding treatment options
Newest EGFR TKIs have changed the game for treating asymptomatic brain metastases
Hall of Fame football player recently revealed his cholangiocarcinoma diagnosis
Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches
Study links strong relationships to better physical and emotional outcomes in myeloma care
Longer gaps between anti-BCMA agents associated with improved response rates, study finds
Experts talk about long-term data and the importance of infection prophylaxis
Response rate of 70% at day 28 with remestemcel-L
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
Alarming mental health challenges among young cancer survivors, especially males, demand action
